UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported): February 10, 2004
ACCREDO HEALTH, INCORPORATED
| Delaware | 000-25769 | 62-1642871 | ||
| (State or Other Jurisdiction of Incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
1640 Century Center Pkway
Suite 101
Memphis, TN 38134
(Address of Principal Executive Offices, including Zip Code)
(901) 385-3688
(Registrant’s telephone number, including area code)
N/A
| ITEM 9. REGULATION FD DISCLOSURE. | ||||||||
| SIGNATURE | ||||||||
| INDEX TO EXHIBITS | ||||||||
| EX-99.1 PRESS RELEASE | ||||||||
ITEM 9. REGULATION FD DISCLOSURE.
On February 10, 2004, Accredo Health, Incorporated (“Accredo”) and Medco Health Solutions, Inc. (“Medco”) announced a 10-year strategic alliance under which Accredo will become the preferred retail and home delivery pharmacy provider to Medco Health members for the specialty product lines that Accredo currently dispenses to treat patients with long-term, chronic diseases. The terms of the agreement have not been disclosed. A copy of Medco’s press release is attached as Exhibit 99.1 to this Current Report on Form 8-K.
-2-
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| ACCREDO HEALTH, INCORPORATED | ||||
| By: | /s/ Thomas W. Bell, Jr. | |||
| Thomas W. Bell, Jr. Senior Vice President and General Counsel | ||||
| Dated: February 10, 2004 | ||||
-3-
INDEX TO EXHIBITS
| EXHIBIT NO. | DESCRIPTION | |
| 99.1 | Press Release, dated February 10, 2004 |
